BCL2L11 and neoplasm: Molecularly, miR-150 directly targets Dyskerin 1 (DKC1) which is a critical regulator of telomerase activity, and deregulates AKT2, thus increasing the levels of two pro-apoptotic tumor suppressors, BIM and TP53 [56].